Farther Finance Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$81.6K Sell
1,850
-137
-7% -$6.06K ﹤0.01% 3022
2026
Q2
$85.3K Sell
1,987
-200
-9% -$7.95K ﹤0.01% 2832
2026
Q1
$84.2K Buy
2,187
+137
+7% +$5.65K ﹤0.01% 2630
2025
Q4
$84.3K Hold
2,050
– – ﹤0.01% 2456
2025
Q3
$76.3K Hold
2,050
– – ﹤0.01% 2198
2025
Q2
$74.7K Buy
+2,050
New +$74.3K ﹤0.01% 1907

Other funds holding BME

Farther Finance Advisors's BME Position: Q3 2026 in Review

Farther Finance Advisors reduced its BlackRock Health Sciences Trust (BME) stake by 6.9% in Q3 2026, selling an estimated $6.06K and leaving 1,850 shares worth $81.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3022.

Farther Finance Advisors first reported a position in BME in Q2 2025 and has held it in 6 quarters since. The position peaked at $85.3K in Q2 2026. 3 funds tracked by Wall St. Rank hold BME as of Q3 2026.

  • Farther Finance Advisors held 1,850 shares of BlackRock Health Sciences Trust worth $81.6K as of Q3 2026.
  • Farther Finance Advisors sold 137 BlackRock Health Sciences Trust shares in Q3 2026, an estimated $6.06K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3022 holding.
  • Farther Finance Advisors first reported a position in BlackRock Health Sciences Trust in Q2 2025 and has held it in 6 quarters since.
  • Farther Finance Advisors's BlackRock Health Sciences Trust position peaked at $85.3K in Q2 2026.
  • 3 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.